Discover how to take Time and Cost out of Clinical Trials in 11 minutes

Niamh Madigan

The proportion of clinical trials in Phase I has increased significantly in the last number of years. This coupled with a number of Phase III failures has put increased emphasis on making the right decision as early as possible. Nancy Widener, Executive Director, Clinical Science and Operations at Bristol Myers Squibb delivers practical tips on how to eliminate errors in early development, thus saving millions of dollars and years of research.... [inlinead]
To continue reading this story get free access